Drug Bioavailability Enhancement Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Drug Class (New Drug Approvals and Generics), Type of BCS Classification (BCS II Drugs and BCS IV Drugs), Type of Bioavailability Enhancement Approach (Solid Dispersion, Size Reduction, Lipid-based, and Other Approaches), Type of Dosage Form (Liquids, Solids, Semi-Solids, and Fine Particles), Key Geographical Regions (North America, Europe and Asia Pacific, Latin America, Middle East, and North Africa)